Management Change3 Jul 2026, 07:00 pm

Bliss GVS Pharma Appoints New Additional Director and CEO

AI Summary

Bliss GVS Pharma Ltd announced key management changes following a Board of Directors meeting held on July 3, 2026. Mr. Santosh Parab has been appointed as an Additional Director (Non-Executive Non-Independent) effective July 3, 2026. Additionally, Mr. Rahul Adakmol will take over as the Chief Executive Officer from July 15, 2026. Mr. Narsimha Shibroor Kamath will step down as CEO on July 14, 2026, but will continue as Managing Director. The company provided brief profiles for the new appointees.

Key Highlights

Santosh Parab appointed Additional Director (Non-Executive Non-Independent).
Rahul Adakmol appointed Chief Executive Officer from July 15, 2026.
Narsimha Shibroor Kamath resigns as CEO, continues as MD.
Board meeting held on July 3, 2026, approved the changes.

View BSE Filing

BLISSGVS

Pharmaceuticals

BLISS GVS PHARMA LTD.

Price Impact